Home
About us
Quality
Services
Impurities for sale
Capabilities
Facilities
Acetyl-2-cysteine
 
 IMPURITIES FOR SALE Adapalene

SR.
NO		    PRODUCT

CODE NO

    PHARMACOPIEA     IMPURITIES   IUPAC NAME
1 Acyclovir A-0001 BP Guanine ( Imp B) 2-amino-1,7-dihydro-6H-purin-6-one
2 Acetyl-2-cysteine A-0002 BP Imp D N,s-diacetyl-L-cysteine
3 Adapalene A-0003 INH   a) Bromonapthoic acid
4 Adapalene A-0004 INH   b) methyl-6-bromo-2-naphthoate
5 Adapalene A-0005 INH   c) 2-(1-adamantyl)-anisole
6 Adapalene A-0006 INH   d) Anisole-2-(1-adamantyl)-4-bromo 
7 Adapalene A-0007 INH   e) methyl ester of adapelene 
8 Adapalene A-0008 INH   f) 3,3-diadamantyl-4,4’-dimethoxy biphenyl 
9 Alprazolam A-0009 INH Triazolam  
10 Amlodipine Besilate A-0010 BP Amlodipine Imp D  3-ethyl 5-methyl-2-[(2-aminoethoxy methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate
11 Amlodipine Mesylate A-0011 BP AmlodipineImp D  3-ethyl 5-methyl-2-[(2-aminoethoxy methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate
12 Amoxycillin A-0012 BP a)  imp D a) Sodium salt of amoxicilloic acid 
13 Amoxycillin A-0013  BP b) imp. C b) Diketo piperazine amoxycillin 
14 Ampicillin A-0014 BP a) imp D a) Sodium salt of ampiclloic acid 
15 Ampicillin A-0015  BP b) imp. C b) Diketopiperazine of ampicillin 
16 Amplodipine Maleate A-0016 BP Amlodipine Imp D  3-ethyl 5-methyl-2-[(2-aminoethoxy methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate
17 Anagrelide HCL A-0017 INH   a) Methyl-5-6-dichloro 3,4-dihydro 2[1H]imino quinazolin-3-acetate                                     
18 Anagrelide HCL A-0018 INH   b) Ethyl-5,6-dichloro 3,4-dihydro 2[1H]imino quinazolin-3-acetate hydrobromide
19 Anagrelide HCL A-0019 INH   c) 6,7,8-trichloro 1,5-dihydro imidazo(2,1-b) quinazolin-2(3H)-one
20 Anagrelide HCL A-0020 INH   d) 5,6-dichloro 3,4-dihydro-amino quinazolin-3-acetic acid                                       
21 Anagrelide HCL A-0021 INH   e) 5,6-dichloro 3,4-dihydro 2[1H] imino quinazolin
22 Anastrozole A-0022 INH   a) a,a,a',a'-Tetramethyl-5(1H-1,3,4-triazol-1-yl-methyl)-1,3-benzene-diacetonitrile
23 Anastrozole A-0023 INH   b) 2,2'-(5-methyl-1,3-phenylene)-di-(2-methyl propiononitrile)
24 Anastrozole A-0024 INH   c) 3,5-bis(cyano-1-methyl ethyl benzyl bromide)
25 Artemether A-0025 INH   a) Dihydroartemisinin
26 Artemether A-0026 INH   b) Alpha- Artemether(Oil cointaining 30% impurity)
27 Artesunate A-0027 INH   Dihydroartemisinin
28 Atorvastatin A-0028 INH   p-hydroxy atorvastatin
29 Atorvastatin A-0029 INH   o-hydroxy atorvastatin
30 Atorvastatin A-0030 INH   atorvastatin acid
31 Beclomethasone  Dipropionate B-0001  BP a) imp J  a) 9,11b-epoxy-16b-methyl-3,20-dioxo-9b-pregna-1,4-diene-17,21-diyl dipropanoate,
32 Beclomethasone  Dipropionate B-0002  BP b) imp H  b) 9-chloro-11b,21-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate (beclometasone 17-propionate), 
33 Beclomethasone  Dipropionate B-0003  BP c) imp G  c) 9-chloro-11b,17,21-trihydroxy-16b-methylpregna-1,4-diene-3,20-dione (beclometasone),
34 Beclomethasone  Dipropionate B-0004  BP d) imp D  d) 9-bromo-11b-hydroxy-16b-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate,
35 Beclomethasone  Dipropionate B-0005  BP e) imp A  e) 9-chloro-11b,17-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-21-yl propanoate (beclometasone 21-propionate),
36 Beclomethasone  Dipropionate B-0006  BP f) imp B  f) 21-(acetyloxy)-9-chloro-11b-hydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate (beclometasone 21-acetate 17-propionate),
37 Beclomethasone  Dipropionate B-0007 INH g) Beclomethasone 21-butyrate g) 9-chloro-11b,17-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-21-yl butanoate
38 Bicalutamide B-0008 INH   a) (±)N-[4-cyano-3(trifluoro methyl)phenyl]-3[(4-fluoro phenyl)thio]-2 hydroxy-2-methyl propanamide
39 Bicalutamide B-0009 INH   b) (±)N-[2-cyano-3(trifluoro methyl)phenyl]-3[(4-fluoro phenyl)sulfinyl]-2-hydroxy-2-methyl propanamide
40 Bicalutamide B-0010 INH   c) (±)N-[4-cyano-3(trifluoro methyl)phenyl]-3[(4-fluoro phenyl)sulfinyl]-2-hydroxy-2-methyl propanamide
41 Brimonidine Tartarate B-0011 INH   a) 5-Bromo, 6- amino quinaxaline
42 Brimonidine Tartarate B-0012 INH   b) 6- amino quinaxaline
43 Budesonide B-0013  BP a) imp D  a) 16a,17-[(1RS)-butylidenebis(oxy)]-11b-hydroxy-3,20-dioxopregna-1,4-dien-21-al,
44 Budesonide B-0014  BP b) imp A  b) 11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione,
45 Budesonide B-0015  BP c) imp F  c) 16a,17-[1-methylethylidenebis(oxy)]-11b,21-dihydroxypregna-1,4-diene-3,20-dione,
46 Budesonide B-0016 INH d) Prednisolone d) 11b,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
47 Budesonide B-0017 INH   e) Acetaldehyde 
48 Capacetabine C-0001 INH   a) 2’3’-di-o-acetyl- 5’ deoxy-5 fluorocytidine 
49 Capacetabine C-0002 INH   b) 4’- bromomethyl-5’-deoxy-5 fluoro-N-[(pentyloxy) carboxyl] cytidine
50 Capacetabine C-0003 INH   c) 2’3’-di-o-acetyl-5’-deoxy-5 fluoro N-[(pentyloxy) carbonyl] cytidine  
51 Capacetabine C-0004 INH   d) 5'-deoxy-5-fluorocytidine
52 Captopril C-0005 BP Imp A (2S,2¢S)-1,1¢-[disulphanediylbis[(2S)-2-methyl-1-oxopropane-3,1-diyl]-bis[pyrrolidine-2-carboxylic] acid (captopril-disulphide).
53 Carboplatin C-0006 INH Cis-iodoplatin  
54 Carboplatin C-0007 BP Imp B cyclobutane-1,1-dicarboxylic acid
55 Carvedilol C-0008  BP a) Imp B a) 1,1¢-[[2-(2-methoxyphenoxy)ethyl]nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol],
56 Carvedilol C-0009 INH   b) Epoxy  Carbazole 
57 Carvedilol C-0010  BP c) Imp A c) 1-[[9-[2-hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]-9H-carbazol-4-yl]oxy]-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol, 
58 Carvedilol C-0011 INH   d) 1-propanol  Carbazole 
59 Carvedilol C-0012 INH   e) C V Side  Chain 
60 Carvedilol C-0013 INH   f) AEP  Compound 
61 Carvedilol C-0014 INH   g) Carvedilol  polymorph  Form-I
62 Carvedilol C-0015  BP h) Imp C h) (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol. 
63 Carvedilol C-0016 INH   i) 4-hydroxy  Carbazole 
64 Celecoxib C-0017 INH   CX-I  Compound
65 Celecoxib C-0018 INH   HSA compound
66 Cetirizine N-oxide C-0019 BP   (RS)-2-[2-(4-(4-chlorophenyl) phenyl methyl] piperazin-1-yl-Noxide) ethoxy] acetic acid
67 Ciclesonide C-0020 INH   a) Ciclesonide-s-isomer (11P,16α)-16,17[[(S)-cyclohexylmethylene] bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy) pregna-1,4-diene,3,20-dione
68 Ciclesonide C-0021 INH   b) Propyl analogue
69 Ciclesonide C-0022 INH   c)  16-α hydroxyl prednisolone
70 Ciclesonide C-0023 INH   d)  n- butyryl derivative
71 Ciclesonide C-0024 INH   e)  Isobytyryl derivative
72 Ciclesonide C-0025 INH   f)  Cyclohexyl derivative
73 Ciclesonide C-0026 INH   g)  Benzyl derivative
74 Citalopram  C-0027 INH   a) Citalopram  Impurity  `B’
75 Citalopram  C-0028 INH   b) Citalopram  Impurity  `D’
76 Citalopram  C-0029 INH   c) Citalopram  Impurity  `A’
77 Citalopram  C-0030 INH   d) Citalopram  Impurity  `C’
78 Citalopram  C-0031 INH   e) Des-bromo Citalopram  Impurity  
79 Citalopram  C-0032 INH   f) 5-chloro  pthalide
80 Clarithromycin C-0033 INH   a) Clarithromycin N-oxide
81 Clarithromycin C-0034 EP b) Imp D  b) N-Desmethyl clarithromycin
82 Clarithromycin C-0035 INH   c) N-Desmethyl Erythromycin A
83 Clarithromycin C-0036 EP d) Imp H d) N-Formyl Clarithromycin
84 Clonazepam C-0037 BP  Imp A a) 2-Amino2-‘-Chloro-5-Nitrobenzophenone 
85 Clonazepam C-0038 USP  Related compound 'B' a) 2-Amino2-‘-Chloro-5-Nitrobenzophenone 
86 Clopidogrel  bisulphate C-0039 INH   a) Racemate  impurity  of  Clopidogrel  
87 Clopidogrel  bisulphate C-0040 INH   b) Acid  Impurity  of  CLP
88 Desloratidine D-0001 INH   a) N-formyl Desloratidine
89 Desloratidine D-0002 INH   b) Loratidine
90 Diazepam D-0003 USP  Related compound B 3-Amino-6-chloro-1-methyl-4-phenylcarbostyril 
91 Didanosine  D-0004 INH Hypoxanthine  Imp A 1,7-dihydro-6H-purin-6-one (hypoxanthine)
92 Didanosine  D-0005 INH Inosine  Imp B 9-b-D-ribofuranosyl-1,9-dihydro-6H-purin-6-one (inosine)
93 Didanosine  D-0006 INH   2',3'-dideoxy-2',3'-didehydro inosine sodium
94 Domperidone  D-0012   Impurity B 4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine
95 Donepezil HCL  D-0007 INH   a) 4-[(5,6-Dimethoxy-1-indanon-2-yl)methylene]pyridine
96 Donepezil HCL  D-0008 INH   b) 1-Benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methylene]pyridine bromide
97 Donepezil HCL  D-0009 INH   c) 2-(4-Piperidinylmethyl)-5,6-dimethoxy-1-indanone
98 Donepezil HCL  D-0010 INH   d) 1-Benzyl-4-[5,6-dimethoxy-1-oxoindan]methyl pyridine
99 Duloxetine Hydrochloride D-0011 INH DLX Racemic mixture  (±)-N-Methyl-3-(1-napthalenyloxy)-3-(2-thienyl) propanaminoxalate
100 Ebastin E-0001 INH N oxide 
101 Ebastin E-0002 INH Pentyl impurity  
102 Emtricifabine E-0003 INH   a) Emtricifabine Carboxylic acid impurity
103 Emtricifabine E-0004 INH   b) Isomer impurity of Emtricifabine:-
104 Emtricifabine E-0005 INH   c) 4-Amino, 6fluoro 1-[(2R,5S)-2(hydroxy methyl)- 1,3 oxathiolan-5-yl}-2(1H) pyrimidinone
105 Emtricifabine E-0006 INH   d) Emtricitabine hydroxy Impurity 
106 Emtricifabine E-0007 INH   e) Emtricitabine sulfoxide Impurity
107 Es-omeprazole magnesium dihydrate E-0008 INH N-oxide impurity   5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole-1'-oxide
108 Es-omeprazole magnesium dihydrate E-0009 INH Sulphone impurity  5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl]sulphonyl]-1H-benzimidazole
109 Es-omeprazole magnesium dihydrate E-0010 INH Desmethoxy impurity  5-Methoxy-2-[[(3,5-dimethylpyridine-2-yl]methyl]sulphinyl]-1H-benzimidazole 
110 Es-omeprazole magnesium dihydrate E-0011 INH Sulphide impurity  5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl-methylthio)1H-benzimidazole
111 Esomeprazole magnesium trihydrate E-0012 INH Omeprazole sulphone  5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl]sulphonyl]-1H-benzimidazole
112 Esomeprazole magnesium trihydrate E-0013 INH Omeprazole sulphide  5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl-methylthio)1H-benzimidazole
113 Esomeprazole magnesium trihydrate E-0014 INH Omeprazole  N-oxide  5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole-1'-oxide
114 Estramustine E-0015 INH   a) Estramustine 
115 Estramustine E-0016 INH   b) 17-b  phosphate  estradiol
116 Etoposide E-0017 BP  Imp D (lignan P)  (5R,5aR,8aR,9S)-9-(b-D-glucopyranosyloxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (lignan P)
117 Etoposide E-0018 INH    4’ de methyl epipodophyllotoxin
118 Etoposide E-0019 BP  Impurity C  (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-ethylidene]-a-D-glucopyranosyl]oxy]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (a-etoposide)
119 Etoposide E-0020 BP Impurity B (5R,5aS,8aR,9S)-9-[[4,6-O-[(R)-ethylidene]-b-D-glucopyranosyl]oxy]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (picroethylidene-lignan P; cis-etoposide)
120 Etoposide E-0021 INH   4’-O-Carbobenzyloxy 4’-demethyl epipodophyllotoxin
121 Etoposide E-0022 BP  impurity A (5R,5aR,8aR,9S)-5-[4-[[(benzyloxy)carbonyl]oxy]-3,5-dimethoxyphenyl]-9-[[4,6-O-[(R)-ethylidene]-b-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (4¢-carbobenzoyloxyethylidene-lignan P)
122 Etoposide E-0023 BP  Imp I  (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-ethylidene]-b-D-glucopyranosyl]oxy]-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (4-O-methylethylidene-lignan P)
123 Etoposide E-0024 BP Imp K 9,9'-oxybis [(5r,5aR,8aR,9s)-5-(4-hydroxy-3,5-dimethoxyphenyl)--5,8,8a,9-tetrahydroisobenzofuro [5,6-F] [1,3] benzodioxol-6(5aH)-one] (di-4'-o-demethylpipodophyllotoxin)
124 Famciclovir F-0001 INH   a) Famciclovir  Impurity-1
125 Famciclovir F-0002 INH   b) Famciclovir  Impurity-2
126 Famciclovir F-0003 INH   c) Des acetyl famciclovir
127 Famotidine F-0004  BP a) Imp C a) 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]-N-sulphamoylpropanamide,
128 Famotidine F-0005  BP b)  Imp D b) 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide, 
129 Famotidine F-0006  BP c) Imp F c) 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic acid, 
130 Famotidine F-0007 BP Imp B 3,5-bis[2-[[[2-[(diaminomethylene) amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide
131 Felodipine F-0008 BP  imp A Ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
132 Felodipine F-0009 BP Imp B Dimethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
133 Felodipine F-0010 BP  Imp C  Diethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
134 Felodipine F-0011 USP  Related compound  A Ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
135 Fenoteral Hydro bromide F-0012  BP a)  Imp A a) (1RS)-1-(3,5-dihydoxyphenyl)-2-[[(1SR)-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethanol, 
136 Fluconazole F-0013 INH   a) Fluconazole  Form-I
137 Flutamide F-0014 BP  imp A 4-Nitro-3-trifluoromethylaniline
138 Flutamide F-0015 BP  Imp D 3-trifluoromethylaniline
139 Flutamide F-0016 INH   3-trifluoromethylisobutyranilide
140 Flutamide F-0017 INH   ortho flutamide
141 Fluticasone  propionate F-0018  BP a)  Imp A a)6a,9-difluoro-11b-hydroxy-16a-methyl-3-oxo-17-(propanoyloxy)androsta-1,4-diene-17b-carboxylic acid,
142 Fluticasone  propionate F-0019  BP b)  Imp F b) 6a,9-difluoro-17-[[(fluoromethyl)sulphanyl]carbonyl]-16a-methyl-3,11-dioxoandrosta-1,4-dien-17a-yl propanoate,              
143 Fluticasone  propionate F-0020  BP c) Imp H c) 17,17¢-(disulphanediyldicarbonyl)bis(6a,9-difluoro-11b-hydroxy-16a-methyl-3-oxoandrosta-1,4-dien-17a-yl) dipropanoate, 
144 Fluticasone  propionate F-0021 INH   d) S-methyl  Fluticasone  propionate 
145 Fluticasone  propionate F-0022 INH   e) Fluticasone  base 
146 Fluticasone  propionate F-0023 INH   f) Fluticasone  acetate 
147 Fluticasone  propionate F-0024 INH   g) Dimmer  impurity  of  Fluticasone  Propionate 
148 Fluticasone  propionate F-0025 INH   h) Fluticasone  Stage-V  (iodo fluticasone)
149 Fluticasone  propionate F-0026 INH   i) Fluticasone  Stage-III  (thio propionate)
150 Formoteral F-0027  BP a) Imp A a) 1-(3-amino-4-hydroxy phenyl)-2-[[2-(4-methoxyphenyl)- 1-methyl ethyl}amino} ethanol
151 Formoteral F-0028 BP b) Imp C b) N-[2-hydroxy-5[1-hydroxy-2-[[2-(4-methoxyphenyl-1-methyl ethyl] amino] ethyl]phenyl] acetonide
152 Gabapentin G-0001 INH   3,3-pentamethylene-5-butyrolactam
153 Gatifloxacin sesquihydrate G-0002 INH   Desmethyl Gatifloxacin
154 Gatifloxacin sesquihydrate G-0003 INH   Gatifloxacin ester
155 Gatifloxacin sesquihydrate G-0004 INH                                               
156 Granisetron Hydrochloride  G-0005 BP  imp A 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide
157 Granisetron Hydrochloride  G-0006 BP  Imp B N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
158 Granisetron Hydrochloride  G-0007 BP  Imp D 1-methyl-1H-indazole-3-carboxylic acid 
159 Granisetron Hydrochloride  G-0008 BP  Imp E (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine  
160 Imatinib mesylate  I-0001 INH   a) N-(2-Methyl-5-amino phenyl)-4-(3-Pyridyl)-2-Pyrimidine Amine.
161 Imatinib mesylate  I-0002 INH   b) 4-[(4-Methyl-1-Piperazinyl) methyl]-N-[4-methyl-3-[4-(3-Pyridinyl)-2-Pyrimidinyl] chloromethyl amino] phenyl] Benzamide.
162 Irinotican Hydrochloride Trihydrate I-0003 INH   a) 7-ethyl camptothecin
163 Irinotican Hydrochloride Trihydrate I-0004 INH   b) 10-hydroxy-7-ethyl camptothecin
164 Lamivudine L-0001 INH   a) 4-Amino-1-(2-(hydroxymethyl) 1,3 oxathiolan-5-yl}-2(1H) pyrimidinone
165 Lamivudine L-0002 BP b) Imp A b) Carboxylic  acid  impurity  of  Lamivudine
166 Lamivudine L-0003 INH   c) Salicylic acid
167 Lamotrigine L-0004 INH   a) 2,3-dichlorobenzoylcyanide
168 Lamotrigine L-0005 INH   b) 1-(1’cyano,1-amino guanidine),2,3-dichlorobenzene 
169 Lansoprazole L-0006 INH Pharmeuropa Imp B  2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulphonyl]-benzimidazole
170 Lansoprazole L-0007 INH Lansoprazole Sulphide  2-[{[3-methyl-4-(2,2,2-trifluoro ethoxy)-2-pyridinyl]-methyl}thio]-1H-benzimidazole
171 Lansoprazole L-0008 INH Lansoprazole N-oxide     2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl-1H-benzimidazole-1-oxide
172 Leflunomide L-0009 INH   a) N-(4-trifluoro methyl phenyl)-2-cyano-3-hydroxy crotonamide
173 Leflunomide L-0010 INH   b) 2-Ethoxy methylene acetoacetic acid-4-trilfuoromethyl anilide
174 Leflunomide L-0011 INH   c) 5-Methylisoxazole-4-carboxylic acid
175 Leflunomide L-0012 INH   d) 3-Methyl-N-[4-trifluoromethyl)phenyl]-4-isoxazole carboxamide
176 Letrozole L-0013 INH   a) 4-fluorobenzonitrile
177 Letrozole L-0014 INH   b) (1H-1,2,4-triazol-1-yl-methylene)4-benzonitrile
178 levofloxacine Hemihydrate L-0015 INH   a) (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxi-7H-pyrido[1,2,3-del]-1,4-benzoxazine-6-carboxylic acid
179 levofloxacine Hemihydrate L-0016 INH   b) Chloromethyl ester impurity
180 levofloxacine Hemihydrate L-0017 INH   c)N-Ethyl Levofloxacin impurity
181 Losartan potassium L-0018 INH   a) LSR-I compound
182 Losartan potassium L-0019 INH   b) TTBB
183 Losartan potassium L-0020 INH   c) BCFI
184 Losartan potassium L-0021 INH   d) Triphenyl methanol
185 Mebendazole M-0001 BP  Imp A a) (2-Amino-1H-benzoimidazole-5-yl) phenyl- methanone 
186 Mitoxantrone Hydrochloride M-0002 INH   Leuco 1,4,5,8-tetrahydroxy anthraquinone
187 Mometasone  furoate M-0003 INH   a) Mometasone  base 
188 Mometasone  furoate M-0004 INH   b) Mometasone  difuroate 
189 Mometasone  furoate M-0005 INH   c) 21-hydroxy  Mometasone  Furoate 
190 Mometasone  furoate M-0006 INH   d) mometasone  furoate epoxide
191 Nevirapine N-0001  BP a) Imp C a) 4-methyl-11-propyl-5,11-dihydro-6H-dipyrido[3,2-b:2¢,3¢-e][1,4]diazepin-6-one. 
192 Nevirapine N-0002 BP b)  Imp A b) 11-ethyl-4-methyl-5,11-dihydro-6H-dipyrido [3,2-b:2¢,3¢-e][1,4]diazepin-6-one,  
193 Nifedipine N-0003  BP a) Imp A a) dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (nitrophenylpyridine analogue),
194 Nifedipine N-0004 BP b) Imp B b) dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate (nitrosophenylpyridine analogue), 
195 Nifedipine    N-0005 USP Nitrophenylpyridine Analog Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
196 Nifedipine    N-0006 USP Nitrosophenylpyridine Analog Dimethyl 4-(2-nitrosophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
197 Norfloxacin N-0007 INH   a) N-5  Compound 
198 Norfloxacin N-0008 INH   b) N-7  Compound
199 Norfloxacin N-0009 INH   c) Chloro analogue  of  Norfoxacin 
200 Ofloxacin O-0001 BP  imp A 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
201 Ofloxacin O-0002 BP  Imp E 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
202 Olanzapine O-0003 INH   a) Olanzapine ethyl  analogue 
203 Olanzapine O-0004 INH   b) 4-hydroxy  impurity of Olanzapine 
204 Olanzapine O-0005 INH   c) Olanzapine  Form-II
205 Olanzapine O-0006 INH   d) Olanzapine  Form-I
206 Olanzapine O-0007 INH   e) Des-N-Methyl  Olanzapine 
207 Olanzapine O-0008 INH   f) ZP-I  Compound 
208 Olanzapine O-0009 INH   g) ZP-II  Compound 
209 Olanzapine O-0010 INH   h) ZP-III  Compound 
210 Omeprazole  O-0011 BP  imp A 5-methoxy-1H-benzimidazole-2-thiol.
211 Omeprazole Magnesium O-0012 BP Imp B 2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole.
212 Omeprazole Sodium O-0013 BP  Imp C  5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]thio1H- benzimidazole. (ufiprazole)
213 Omeprazole Sodium O-0014 BP  Imp D 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole(omeprazole sulphone)
214 Omeprazole Sodium O-0015 BP  Imp E 4-methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulphinyl]methyl]-3,5-dimethylpyridine 1-oxide
215 Omeprazole Sodium O-0016 INH B5 Hydrochloride 2-hydroxymethyl 3,5-dimethyl-4-methoxy pyridinehydrochloride
216 Ondansetron  hcl  O-0017  BP a) Imp A a) (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one,
217 Ondansetron  hcl  O-0018 BP b) Imp C b) 9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one, 
218 Ondansetron  hcl  O-0019 BP c) Imp D c) 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one,
219 Ondansetron  hcl  O-0020 BP d) Imp G d) (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-demethylondansetron), 
220 Ondansetron  hcl  O-0021  BP e) Imp H e) (3RS)-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one (N-demethylondansetron).
221 Ondansetron  hcl  O-0022 USP  Related compound  A 3[(dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
222 Ondansetron  hcl  O-0023 USP  Related compound  D 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one
223 Ondansetron  hcl  O-0024 USP Related Compound C 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one
224 Ornidazole O-0025 INH   a) Ornidazole epoxide
225 Ornidazole O-0026 INH   b) Ornidazole diol
226 Oxaliplatin O-0027 BP  impurity A ethanedioic acid (oxalic acid)
227 Pantoprazole sodium P-0001 INH Pharmeuropa Imp A Pantoprazole sulphone is 5(Difluoro methoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole
228 Pantoprazole sodium P-0002 INH Pantoprazole sulphide  5-(Difluoromethoxy)-2-[[3,4-dimethoxy-2-pyridinyl]methyl]thio]-1H-benzimidazole
229 Pantoprazole sodium sesquihydrate P-0003 INH Pantoprazole sulphone-N-oxide  5-(Difluoro methoxy)-2-[[3,4-dimethoxy-2-pyridin-1-oxidenyl]methyl]sulphonyl]-1H-benzimidazole
230 Paroxetine  hydrochloride P-0004 INH   a) PR-VI  Compound 
231 Paroxetine  hydrochloride P-0005 INH   b) PR-VII  Compound 
232 Potassium Clavulanate P-0006  BP a)  Imp A a) 2,2’-(pyrazine-2,5-diyl)diethanol
233 Potassium Clavulanate P-0007 BP b) Imp B b) 3-[3,6-bis(2-hydroxyethyl) pyrazine- 2-yl}-propanoic acid 
234 Potassium Clavulanate P-0008 BP c)  Imp C c) 2,2’-(3-Ethyl pyrazine-2,5-diyl Diethanol
235 Pramipexole P-0009 INH   a) Pramipexole  impurity  `E’ 
236 Pramipexole P-0010 INH   b) PX-6  Compound 
237 Pramipexole P-0011 INH   c) Impurity  `D’  of  Pramipexole 
238 Pramipexole P-0012 INH   d) Impurity  `F’  of  Pramipexole 
239 Pramipexole P-0013 INH   e) Impurity  `A’  of  Pramipexole 
240 Pramipexole P-0014 INH   f) Pramipexole  racemate  compound 
241 Quetiapine fumarate Q-0001 INH   a) QTPP --- IMP A
242 Quetiapine fumarate Q-0002 INH   b) Qtp-04—imp B 
243 Rabeprazole sodium R-0001 INH   a) 2-[[[4-(3-Methoxy propoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
244 Rabeprazole sodium R-0002 INH   b) 2-[[[4-(3-Methoxy propoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
245 Rabeprazole sodium R-0003 INH   c)  2-[[[4-(3-Methoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
246 Raloxifene HCL R-0004 INH   a) 6-Methyl sulfonyloxy-2-[(4-methyl sulfonyloxy) phenyl-3[4(2-(piperidinyl)ethoxy]-benzoyl]benzothiophene hydrochloride
247 Raloxifene HCL R-0005 INH   b) 6-Hydroxy-2[4-hydroxy phenyl]-3[4-hydroxy benzoyl]benzothiophene
248 Ramipril R-0006 BP a) Imp E a) (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-carboxy-3-phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril diacid), 
249 Ramipril R-0020 BP Imp D(Ramipril diketopiperazine) ethyl(2S)-2[(3s,5as,8as,9as)-3-methyl-1,4-dioxodecahydro-2H-cyclo penta[4,5] pyrrolo [1,2-a] pyrazine-2-yl]-4-penhylbutanoate
250 Ramipril R-0021 BP Imp L(Ramipril hydroxy diketopiperazine) ethyl(2S)-2[(3s,5as,8as,9as)-9a-hydroxy-3-methyl-1,4-dioxodecanhydro-2H-cyclopenta[4,5] pyrrolo [1,2-a] pyrazin-2-yl]-4-phenyl butanoate 
251 Ranitidine R-0007 USP a)  Related compound c a) N-[2-[[[5-[(dimethylamino) methyl]-2-furanyl] methyl] sulphinyl] ethyl ]- N-methyl- 2-Nitro1-1 Ethene diamine 
252 Ranitidine R-0008 USP b)  Related compound A b) [5-[[2-aminoethyl) thio] methyl]-N-N-dimethyl-2- furan methanamine, hemifumarate salt] 
253 Ranitidine R-0009 BP a) imp B a) 2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethanamine, 
254 Ranitidine R-0010 BP b) imp F b) [5-[(dimethylamino)methyl]furan-2-yl]methanol, 
255 Ranitidine R-0011 BP c) imp G c) 3-(methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one-oxime, 
256 Rifampicin R-0012 INH   a) 3-Formylrifamycin sv
257 Rifampicin R-0013 INH   b) Isonicotinyl hydrazone of rifampicin and isoniazide
258 Risperidone R-0014 INH    a) 4-(2,4-Difluoro benzoyl hydroxylamino)piperidine
259 Risperidone R-0015 INH    b) 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole monohydrochloride
260 Risperidone R-0016 INH   c) 3-(2-chloroethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
261 Risperidone R-0017 INH   d) 6,7,8,9-tetrahydro-2-methyl-3-(2-chloroethyl)-4H-pyrido(1,2-a)pyrimidine-4-one hydrochloride
262 Risperidone R-0018  BP e) Imp C e)3-(2-(-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
263 Risperidone R-0019 INH f) Risperidone N-oxide  
264 Salbutamol sulfate S-0001  BP a) Imp C a) (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxy-3-methylphenyl)ethanol, 
265 Salbutamol sulfate S-0002  BP b) Imp D b) 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-hydroxybenzaldehyde, 
266 Salbutamol sulfate S-0003  BP c) Imp I c) (1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4-benzyloxyphenyl]ethanol. 
267 Salmeterol Xinofoate S-0004 BP a) Imp G a) 1-[4-hydroxy-3-[[[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl][6-(4-phenylbutoxy)hexyl]amino]methyl]phenyl]-2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol. 
268 Salmeterol Xinofoate S-0005 INH   b) 1-hydroxy-4[[2-hydroxy-5-[1-hydroxy-2-[[6-(-(4-Phenyl butoxy) hexyl] amino]ethyl] phenyl] methyl]-2-naphthalenecarboxylic acid
269 Salmeterol Xinofoate S-0006  BP           c) 1-[4-hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(1-methyl-3-phenylpropoxy)hexyl]amino]ethanol, 
270 Selegiline Hydrochloride S-0007 BP  Imp A (2RS)-N-methyl-1-phenylpropan-2-amine [(RS)-metamphetamine]
271 Sertraline  hydrochloride S-0008 INH   a) IST-01  Compound 
272 Sertraline  hydrochloride S-0009 INH   b) 3,4  des- chloro  Sertraline 
273 Sertraline  hydrochloride S-0010 INH   c) Sertraline  base 
274 Sertraline  hydrochloride S-0011 INH   d) Cis (1R, 4R)  Sertraline  HCl 
275 Sertraline  hydrochloride S-0012 INH   e) NS-II  Compound 
276 Sertraline  hydrochloride S-0013 INH   f) Trans  isomer  of  NS-III  Compound 
277 Sertraline  hydrochloride S-0014 INH   g) NS-III  Compound (Racemic sertraline)
278 Sibutramine S-0015 INH   a) SM-III  fumarate  salt 
279 Sibutramine S-0016 INH   b) SM  amide  impurity 
280 Sibutramine S-0017 INH   c) Des-chloro  Sibutramine 
281 Sildenafil   S-0018 INH   a) Des  methyl  impurity  of  Sildenafil  [3-[2-(dimethyl amino)ethyl]-1-(hydroxymethyl)-1H indol-5-yl] N- methyl methane sulphonamide
282 Stavudine S-0019 BP a)  Imp A a)5-methylpyrimidine-2,4(1H,3H)-dione (thymine)
283 Stavudine S-0020 INH   b) 2’,3’-didehydro,5’-O-Benzoyl,5-methyl uridine
284 Sumatritan succinate S-0021 USP  Imp   Related compound 'C ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
285 Tamsulosin hydrochloride T-0001 INH   a) (R)-5-{2- N,N bis[[2-(2-ethoxy phenoxy )ethyl]-amino]propyl}-2-methoxy benzene sulphonamide
286 Tamsulosin hydrochloride T-0002 INH   b) 2-methoxy-5-[2-(1,methyl benzyl amino) propyl] benzene sulphonamide
287 Tamsulosin hydrochloride T-0003 INH   c) (S)-5-{2-[[2-(2-ethoxy phenoxy ) ethyl)amino]propyl}2- methoxy benzenesulphonamide
288 Tamsulosin hydrochloride T-0004 INH   d) 2-bromoethyl-2-ethoxyphenyl ether
289 Tamsulosin hydrochloride T-0005 BP   (R)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide
290 Tamsulosin hydrochloride T-0006 BP   2-(2-Ethoxyphenoxy)bromethane
291 Tamsulosin hydrochloride T-0007 BP   (R)-5-(2-(bis(2-2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
292 Tegaserod Maleate T-0005 INH   a) 5-Methoxy 1H – Indole 3- carbaldehyde
293 Tegaserod Maleate T-0006 INH   b) N-amino n-pentyl Guanidine
294 Terbinafine hydrochloride T-0007 INH   a) Terbinafine-Z-isomer N-[(2E)-6,6- dimethyl-2-hepten-4ynyl] N-methyl-1-naphthalenemethanamine 
295 Terbinafine hydrochloride T-0008 INH   b) Dimmer impurity of terbinafine
296 Tibolone T-0009 INH   a) α-Tibolone 7α-methyl-17 α-ethynyl-17β hydroxy estr-5(10)-en-3-one
297 Topiramate T-0010 INH    a) 2,3:4,5-bis-O-(1-methylethylidene)-beta D fructopyranose
298 Topiramate T-0011 INH   b) 2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamoyl azide
299 Topotecan Hydrochloride T-0012 INH   a) Camptothecin
300 Topotecan Hydrochloride T-0013 INH   b) 10-Hydroxy camptothecin
301 Torsemide T-0014 USP  Related compound  A (4[(3-methyl phenyl)amino]-3-pyridine sulphonamide)
302 Trimetazidine  dihydrochloride T-0015  BP a) Imp A a) 1-(3,4,5-trimethoxybenzyl)piperazine,
303 Trimetazidine  dihydrochloride T-0016 BP b) Imp C b) 2,3,4  trimethoxy  benzaldehyde 
304 Trimetazidine  dihydrochloride T-0017 BP  c) Imp F c) 2,4,6  trimethoxy  TMZ  impurity 
305 Trimetazidine  dihydrochloride T-0018 BP  d) Imp D d) 2,3,4  trimethoxy  phenyl  methanol 
306 Trimetazidine  dihydrochloride T-0019 BP  e) Imp B e) 1,4-bis(2,3,4-trimethoxybenzyl)piperazine,
307 Trimetazidine  dihydrochloride T-0020 BP  f)  Imp E f) 1-(2,4,5-trimethoxybenzyl)piperazine,
308 Venlafaxine hydrochloride V-0001 BP a) Imp G a) (2RS)-2-cyclohexyl-2-(4-methoxyphenyl)-N,N-dimethylethanamine. 
309 Venlafaxine hydrochloride V-0002  BP b)  Imp D b) 1-[(1RS)-1-(4-methoxyphenyl)-2-(methylamino)ethyl]cyclohexanol, 
310 Vincristine sulphate V-0003 INH Desformyl vincristine  
311 Zidovudine Z-0001 BP  Imp D Triphenyl methanol
312 Zidovudine Z-0002 BP  Imp C  5-methylpyrimidine-2,4(1H,3H)-dione (thymine)

 

Sample COA :
Salmetrol Impurity H

Molecular Formula : C36O6N1H43

Molecular Weight : 585

Batch No.: 040702

Mfg. Date : 20th june 2006

Long Term Storage : 2-8°C, dark

Appearance : Off-white powder

Purity by HPLC (on as is basis) 95.235%

Mass (LCMS) : 586.2

PNMR : Complies
Certificate of Analysis :
BATCH NO. : 040702 SALMETROL IMPURITY H MFG.DT. : JUNE 2006
TEST STANDARD RESULT
APPEARANCE

Off-white powder

Meets the requirement
IDENTITY

585

586.2

PURITY

NLT 95%

95.24%

PNMR

Meets the requirements under the test

Meets the requirement
REMARK : COMPLIES AS PER THE STANDARDS
QUALITY CONTROL :

DATE:  02/12/2006
 		 QUALITY ASSURANCE:   

DATE  :  04/12/2006
   
 
© 2006 Pharmasolve Specialities (I) PVT. LTD.
Designed by: Equal
Acyclovir